The groundbreaking SPF technology is specifically designed and formulated to prevent sunburn or sun damage while allowing the passage of sufficient UVB light that our bodies use to naturally produce vitamin D
A. Menarini India, part of the Menarini Group, the world's largest Italian biopharmaceutical company, announces the launch of ‘Solar D’ sunscreen – a breakthrough innovation in dermatology in over 70 years, the company said in a release.
Designed for everyone from individuals stepping outdoors to serious athletes, this revolutionary SPF 50, water and sweat-resistant sunscreen, uses a unique UV activated vitamin D technology that allows your body to naturally produce Vitamin D while protecting your skin from burning, ageing, and tanning.
The groundbreaking SPF technology is specifically designed and formulated to prevent sunburn or sun damage while allowing the passage of sufficient UVB light that our bodies use to naturally produce vitamin D. It uses compounds with differing filter compositions that enable and maximizes vitamin D production while maintaining its broad-spectrum sun protection.
Non-oily, PA++++ protection grade, and easy to blend, Solar D SPF 50 is essential for all outdoor warriors, and people with sensitive skin including children over 6 months. Perfect for those who bike, hike, or enjoy water sports, Solar D SPF 50 is water-resistant & sweat resistant for up to 120 minutes, allowing them to get maximum work. The sunscreen is free of oil and fragrances.
Commenting on the launch, Girisan Kariangal, Managing Director, Menarini India said, “Sunscreens have been well established and documented as effective photoprotective agents for preventing the incidence of human skin disorders. Consumers are now understanding the importance of skincare and are increasingly using sunscreens, making it a part of their lifestyle. With the launch of Solar D sunscreen, we aim to strengthen our dermatology portfolio in India that will offer international innovative solutions for overall skin health.”
Pfizer’s phase 3 studies of novel antibiotic combination offer new hope for patients with multidrug-resistant infections and treatment options
Merck partners with California-based research group to study catalysis innovation through machine learning
Philips and Masimo introduce advanced monitoring capabilities to Philips high acuity patient monitors
Subscribe To Our Newsletter & Stay Updated